Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Targeted gene disruption presented as a potential new HIV therapy

March 8, 2005

ALVAC vCP1452 shows efficacy in preventing viral rebound in HIV-infected patients

March 4, 2005

MVA-nef induces a strong specific immune response in HIV-infected patients

March 4, 2005

SP-01A set to enter phase II/III study in Q2

March 3, 2005

Mechanism of action of the HIV-1 attachment inhibitor, BMS-488043

March 3, 2005

Cytolin decreases viral load and increases T-cell count in HIV-infected patients

March 3, 2005

Good safety profile found for Adenovirus Type-5 HIV vaccines in healthy subjects

March 3, 2005

Prime-boost vaccine regimen active in infants of HIV-infected mothers

March 2, 2005

Recombinant human growth hormone studied in HIV+ patients with lipodystrophy

March 2, 2005

HIV-1 develops resistance to AG-1859 but much slower than to lamivudine

March 1, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...